Hydrochlorothiazide

From Free net encyclopedia

(Difference between revisions)
Revision as of 12:11, 15 February 2006
Diberri (Talk | contribs)
Reverted edits by [[Special:Contributions/68.66.217.238|68.66.217.238]] ([[User talk:68.66.217.238|talk]]) to last version by 83.31.222.230
Next diff →

Current revision

Image:Hydrochlorothiazide.png
Hydrochlorothiazide

6-chloro-3,4-dihydro-2H-
1,2,4-benzothiadiazine-
7-sulfonamide 1,1-dioxide
CAS number
58-93-5
ATC code
C03AA03
Chemical formula C7H8ClN3O4S2
Molecular weight 297.742
Bioavailability Variably absorbed from GI tract
Metabolism  ?
Elimination half-life 5.6-14.8 hours
Excretion Primarily excreted unchanged in urine
Pregnancy category B (D if used to treat pregnancy-induced hypertension)
Legal status By prescription only
Routes of administration Oral (capsules, tablets, oral solution)

Hydrochlorothiazide (Apo-Hydro®, Aquazide H®, Microzide®, Oretic®), sometimes abbreviated HCT, HCTZ, or HZT is a popular diuretic drug that acts by inhibiting the kidney's ability to retain water. This reduces the volume of the blood, decreasing peripheral vascular resistance.

Activity

Hydrochlorothiazide belongs to the thiazide class of diuretics, acting on the kidney to reduce sodium (Na) reabsorption in the distal convoluted tubule. This reduces the osmotic pressure in the kidney, causing less water to be reabsorbed by the collecting ducts.

Indications

HCT is often used to treat hypertension, congestive heart failure and symptomatic edema. It is effective in diabetes insipidus and is also sometimes used in hypercalciuria.

Hypokalemia, an occasional side-effect, can be usually prevented by potassium supplements or combining hydrochlorothiazide with a potassium-sparing diuretic.

Side effects

pl:Hydrochlorotiazyd